Digital Marketing, e-Resourcing and Social Media Marketing in Pharma
Home > Pharma Marketing > US FDA warns pharma firm about Facebook promotion

US FDA warns pharma firm about Facebook promotion

Looks like Novartis are the first pharma company to have had their knuckles wrapped by the FDA over social media promotion, after they include a Facebook share link on a website. “…to promote Tasigna is incomplete and misleading”

Read the Letter from the FDA here (PDF)

http://www.macworld.co.uk/digitallifestyle/news/index.cfm?olo=rss&NewsID=3234596

Related posts:

  1. Social Media “guidelines” in Pharma
Categories: Pharma Marketing Tags: